| http://www.w3.org/ns/prov#value | - antiarrhythmic therapy [66].This variability in the risk of torsade de pointes involves defining the molecular mechanisms that control the duration of action potential and the QT interval in the normal heart and in diseases such as the congenital long QT syndrome or heart failure.
|
